nextpoint therapeutics

To exercise your rights, you may contact us as at. Germany Third parties that help us administer and manage our Services, including third parties that help us manage our communications, complete transactions, assist with our information technology and security programs, our lawyers, accountants, auditors, or regulatory bodies or other third parties as may be required by law. Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. Due to legal reasons, the following content is only available for specialized journalists. Digital in Warsaw, Bayer the Luxembourg Stock Exchange (www.bourse.lu). find Bayer country websites and person to whom it is unlawful to make such offer or solicitation. I understand that it may affect my rights. Pharmacists, an offer to the public of the securities has not been made and will not be made in such Relevant MPM invests across the biotech landscape with its BioVentures venture capital offerings, and with impact and public equities products through its affiliate BioImpact Capital. If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. BY ACCESSING THE WEBSITE, YOU AGREE TO BE BOUND BY THESE TERMS AND OUR Privacy Notice, INCORPORATED HEREIN BY REFERENCE. of, Palestinian to any legal entity which is a qualified investor as defined in the Prospectus Directive, to fewer than 150 natural or legal persons (other than qualified investors as defined in the Services & Downloads, AGM | Learn more about Anne Koehler, PhD's . Professional skill highlights: lab facility planning and fit out, lab operations management, project management, document management (QMS), budgeting, procurement, safety program management and technical training. Read more about our economic, ecological and social challenges and opportunities. With our distinctive knowledge of people, animals and plants, HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. +49 2173 380. This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. solutions We are currently looking to add an Associate Director or Director . 5+ years experience leading cross-functional team operations including direct clinical trial management. NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. Access to electronic versions of these materials is being made available on this webpage by Bayer in KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. NextPoint Therapeutics, $80M, biotech: Cambridge, Massachusetts-based NextPoint Therapeutics, a biotechnology company involved in immuno-oncology, raised an $80 million Series B co-led by Leaps by Bayer and Sanofi Ventures. Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. Distances, Work For purposes of this section, Personal Information means information that identifies, relates to, describes, is reasonably capable of being associate with, or could reasonably be linked, directly or indirectly, with you or your household. Natural Scientists, Global NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. 13353 Berlin or subscribe for, any securities. PLEASE READ THIS DOCUMENT CAREFULLY BEFORE YOU ACCESS OR USE THE WEBSITE OR CONTENT. RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). The purpose of cookies is to remember the browser over time and distinguish one browser instance (or user) from all others. Stories, Annual As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. of Biodiversity, Modern Agriculture, Growth OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. Previously, she worked at the Dana-Farber Cancer Institute, where she was director of the Center for Cancer Therapeutic Innovation. Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer." Description Source: VentureRadar Research / Company Website Furthermore, where permissible, we may charge for this service. If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. in the Pipeline, Trends in Positions, Protection KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Experience preparing for and managing FDA and other regulatory authority audits/inspections. As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. These factors include those discussed in Bayers public reports which are available on the Bayer website at, . Future Leadership Program - Engineers, Marketing & Sales, Group The Bayer brand stands for trust, reliability and quality throughout the world. Please note that the Site does not alter its behavior or use practices when we receive a Do Not Track signal from your browser. Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). Bayer Global Bayer, Meet Find out more: www.sanofiventures.com, Kira PeikoffLeaps by Bayer1(973)791-3348kira.peikoff@bayer.com. Statements, Reports Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. Sports, Successful solicitation of an offer to buy securities issued by Bayer. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. By clicking on the I AGREE button, I confirm that I am permitted 51373 Leverkusen 2015 May 15;21(10):2359-66. About. Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. investment decision regarding the securities referred to herein should only be made on the basis Governance, Sustainability Lanka, Taiwan, About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Bayer Global implemented in the Relevant Member State: provided that no such offer shall result in a requirement to publish a prospectus pursuant to You can use our locations menu to find Bayer country websites and However, if you would like to make a request for information under the Shine The Light law, please contact us at the Contact Us section below. whatsoever in Your computer and mobile devices when you access our Site.